AmerisourceBergen Corp ABC:NYSE

Last Price$88.24NYSE Previous Close - Last Trade as of 6:30PM ET 12/06/19
NYSE 15-minute delayed Bid/Ask Quotes
Today's Change0(0.00%)
Bid (Size)$73.60 (1)
Ask (Size)$115.00 (1)
Day Low / HighN/A - N/A
Volume728.4 K
 

View Medical Distributors IndustryPeer Comparison as of 12/06/2019

 

AmerisourceBergen Corp ( NYSE )

Price: $88.24
Change: +0.42 (0.48%)
Volume: 728.4 K
6:30PM ET 12/06/2019
 
 

Cardinal Health Inc ( NYSE )

Price: $54.87
Change: +0.62 (1.14%)
Volume: 1.5 M
6:30PM ET 12/06/2019
 
 

McKesson Corp ( NYSE )

Price: $142.27
Change: +1.66 (1.18%)
Volume: 1.4 M
6:30PM ET 12/06/2019
 
 

Henry Schein Inc ( NASDAQ )

Price: $69.42
Change: +0.25 (0.36%)
Volume: 903.7 K
4:00PM ET 12/06/2019
 
 

Patterson Companies Inc ( NASDAQ )

Price: $23.51
Change: +0.41 (1.77%)
Volume: 2.1 M
4:00PM ET 12/06/2019
 

Read more news Recent News

Market Chatter: Federal Prosecutors Reportedly Open Probe of Opioid Makers, Distributors
3:47PM ET 11/26/2019 MT Newswires

Shares of opiod makers and distributors slumped in afternoon trade after the WSJ said federal prosecutors have opened a criminal probe into the role of...

Opioid Makers, Distributors Shares Skid Lower on Federal Criminal Probe Report as Fitch Sees 'Headline Risk'
3:13PM ET 11/26/2019 MT Newswires

Shares of drug-related companies skidded lower on Tuesday amid a report of a possible federal criminal investigation into opioids, while Fitch Ratings said...

AmerisourceBergen's Q3, 2020 and 2021 Earnings Estimates Raised
11:21PM ET 11/22/2019 MT Newswires

Q3, 2020, and 2021`s earnings forecasts for AmerisourceBergen Inc (NYSE:ABC, Recent Price: 90.26) have been scaled up. The Q3 earnings estimate has been...

AmerisourceBergen's Q3, 2020, and 2021 Earnings Scaled Down by Analysts
11:21PM ET 11/21/2019 MT Newswires

AmerisourceBergen Inc's (NYSE:ABC, Recent Price: 88.31) consensus estimates for Q3 ending December 31, 2019, and the forecasts for 2020 and 2021 have been...

Company Profile

Business DescriptionAmerisourceBergen Corp. engages provision of pharmaceutical products and business solutions that improve access to care. It operates through the Pharmaceutical Distribution Services and Other segments. The Pharmaceutical Distribution Services segment distributes a comprehensive offering of brand-name, specialty brand-name & generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies & equipment, outsourced compounded sterile preparations, and related services to a wide variety of healthcare providers, including acute care hospitals and health systems, independent & chain retail pharmacies, mail order pharmacies, medical clinics, long-term care & alternate site pharmacies, and other customers. The Other segment focuses on global commercialization services and animal health and includes ABCS, World Courier, and MWI. The company was founded in 1947 and is headquartered in Chesterbrook, PA. View company web site for more details
Address1300 Morris Drive
Chesterbrook, Pennsylvania 19087-5594
Phone+1.610.727.7000
Number of Employees21,000
Recent SEC Filing12/05/20194
Chairman, President & Chief Executive OfficerSteven H. Collis
Chief Financial Officer & Executive Vice PresidentJames Francis Cleary
Chief Information Officer & Executive VPDale B. Danilewitz
Chief Compliance Officer & Executive OfficerKathy Habecker Gaddes

Company Highlights

Price Open$88.25
Previous Close$87.82
52 Week Range$69.36 - 94.75
Market Capitalization$18.2 B
Shares Outstanding205.9 M
SectorDistribution Services
IndustryMedical Distributors
Current Dividend / Yield$0.40 / 1.81%
Dividend Ex-Date11/15/2019
Dividend Pay-Date12/02/2019
Dividend Yield 5 Year Average1.58%
Next Earnings Announcement01/30/2020

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / Earnings21.90
Earnings per Share$6.52
Beta vs. S&P 500N/A
Revenue$167.9 B
Net Profit Margin0.48%
Return on Equity28.90%

Analyst Ratings as of 12/02/2019

Buy
7
Overweight
0
Hold
11
Underweight
1
Sell
0
Consensus RecommendationConsensus Icon
Powered by Factset